This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_MANTLE_CELL_LYMPHOMA_EXALLC for full statistics.
Mantle cell lymphoma
C3_MANTLE_CELL_LYMPHOMA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
288 |
4. Check minimum number of eventsNone |
288 |
5. Include endpointsNone |
288 |
6. Filter based on genotype QC (FinnGen only) |
288 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Mantle cell lymphoma
based on the number of shared cases.
Similar with more cases:
- Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)
- Non-Hodgkin lymphoma, all
- Non-follicular lymphoma, hilmo, excluding all cancers
- Non-follicular lymphoma
- Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 288 | 61 | 227 |
| Unadjusted period prevalence (%) | 0.08 | 0.02 | 0.10 |
| Median age at first event (years) | 70.21 | 68.04 | 70.79 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 276
- Matched controls
- 2759
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
323.0
275
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
338.4
262.5
248
69
XW000
NOMESCO Finland
Bone marrow biopsy
57.8
133.8
159
63
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
108.8
125.9
132
23
WW500
NOMESCO Finland
Blood transfusion
41.7
104.5
133
60
L03AA02
ATC
filgrastim; parenteral
53.6
102.5
122
40
L03AA13
ATC
pegfilgrastim; parenteral
57.9
95.9
112
32
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
36.5
95.1
125
61
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
+∞
93.1
84
*
M04AA01
ATC
allopurinol; systemic
16.5
92.9
192
335
JN4BD
NOMESCO Finland
Extensive body CT
15.8
80.2
151
195
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
83.9
79.5
87
15
A03FA01
ATC
metoclopramide; systemic, rectal
11.4
70.8
169
334
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
19.9
70.1
112
91
WW300
NOMESCO Finland
Transfer of autologic stem cells
298.8
69.7
68
*
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
+∞
57.3
53
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
19.3
55.0
87
64
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
54.9
54.5
64
15
D70.82
ICD-10 Finland
Drug-induced neutropenia
53.8
53.5
63
15
1XC02
NOMESCO Finland
NA
111.3
50.9
54
6
A49.9
ICD-10 Finland
Bacterial infection, unspecified
8.9
48.4
120
218
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
26.2
46.3
65
32
9673/3-C77.8
ICD-O-3
Mantle cell lymphoma of lymph nodes of multiple regions
+∞
46.1
43
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
98.9
45.5
49
6
L03AA14
ATC
lipegfilgrastim; parenteral
63.6
45.5
52
10
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
51.1
45.4
54
13
A04AA01
ATC
ondansetron; systemic, rectal
12.3
44.9
87
99
JN6AD
NOMESCO Finland
CT of torso and neck
37.4
44.8
57
19
PJA10
NOMESCO Finland
Exploration of lymph nodes
49.2
41.0
49
12
H02AB06
ATC
prednisolone; systemic
6.2
40.7
212
964
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
20.8
37.9
57
34
ZX120
NOMESCO Finland
Intravenous
8.4
37.7
92
154
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
79.7
37.1
41
6
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
103.0
33.6
36
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
25.4
33.6
47
22
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
43.4
33.5
41
11
R50.9
ICD-10 Finland
Fever, unspecified
6.0
31.8
104
254
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.9
30.8
70
101
JN4AD
NOMESCO Finland
Body CT examination
7.2
29.7
79
145
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
41.1
29.2
36
10
A04AA02
ATC
granisetron; systemic, transdermal
9.0
29.0
65
91
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
87.0
28.4
31
*
J05AB11
ATC
valaciclovir; oral
6.5
28.3
82
168
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
9.3
27.1
59
78
WW402
NOMESCO Finland
Leucoferesis
+∞
26.5
25
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
29.5
25.5
34
13
WW409
NOMESCO Finland
Other aferesis
273.5
25.1
25
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
20.5
24.2
36
20
TGC00
NOMESCO Finland
Bronchial lavation
14.9
23.3
39
30
ZX112
NOMESCO Finland
Subcutaneous
16.3
22.4
36
25
YNB10
NOMESCO Finland
Collection of stem cells for transplant
226.1
20.9
21
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.5
20.4
136
601
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
62.3
20.2
23
*
212
Kela drug reimbursment
Gout
12.0
20.1
37
35
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
20.0
19
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
113.1
19.8
21
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
12.0
19.1
35
33
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
16.7
18.9
30
20
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
9.8
18.6
38
44
ZX108
NOMESCO Finland
Inhalation
24.8
18.1
25
11
390
Kela drug reimbursment
Ibrutinib
45.2
17.5
21
5
A02BC02
ATC
pantoprazole; systemic
3.4
17.5
215
1411
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.3
17.4
72
209
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
37.6
16.9
21
6
9673/3-C09.9
ICD-O-3
Mantle cell lymphoma of tonsil, NOS
+∞
16.8
16
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
16.2
174
1013
D64.9
ICD-10 Finland
Anaemia, unspecified
4.2
15.9
66
191
1AA09
NOMESCO Finland
NA
+∞
15.8
15
*
J01MA12
ATC
levofloxacin; systemic
3.3
15.8
100
408
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
17.4
15.5
24
15
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.9
14.8
119
567
EMA10
NOMESCO Finland
Biopsy of tonsil
+∞
14.7
14
*
L01XE27
ATC
[U] ibrutinib; oral
157.8
14.6
15
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.6
14.1
42
85
L01AA02
ATC
chlorambucil; oral
56.3
14.0
16
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
7.2
13.9
34
53
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
13.1
79
307
WZC30
NOMESCO Finland
Teaching
3.4
12.5
68
243
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
135.8
12.5
13
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
135.8
12.5
13
*
N02AA05
ATC
oxycodone; systemic
3.2
12.5
76
295
Z51.5
ICD-10 Finland
Palliative care
4.4
12.4
47
124
H02AB07
ATC
prednisone; oral
3.4
12.2
65
227
1512
Kela drug reimbursment
Ibrutinib
31.5
11.8
15
5
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
31.5
11.8
15
5
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
24.1
11.7
16
7
R06AE07
ATC
cetirizine; oral
2.6
11.7
116
604
D70.89
ICD-10 Finland
Neutropenic splenomegaly
14.7
11.1
18
13
D69.5
ICD-10 Finland
Secondary thrombocytopenia
45.2
11.0
13
*
WX110
NOMESCO Finland
Local anesthesy
2.4
10.7
187
1287
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.7
10.7
49
153
WF004
NOMESCO Finland
Palliative radiotherapy
7.6
10.5
24
34
B02.9
ICD-10 Finland
Zoster without complication
4.9
10.4
34
77
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
19.7
10.4
15
8
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
11.2
9.9
18
17
EMB10
NOMESCO Finland
Tonsillectomy
10.1
9.9
19
20
H02AB02
ATC
dexamethasone; systemic
3.5
9.9
49
162
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
20.9
9.9
14
7
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
57.0
9.7
11
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
7.1
9.7
23
35
C81.3
ICD-10 Finland
Lymphocyte depleted classical Hodgkin lymphoma
+∞
9.4
9
*
9673/3-C80.9
ICD-O-3
Mantle cell lymphoma of unknown primary site
+∞
9.4
9
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.4
9.2
92
470
WW200
NOMESCO Finland
Immunization
6.9
9.2
22
34
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
16.3
9.1
14
9
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.9
9.0
29
65
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
51.6
8.7
10
*
XX3DW
NOMESCO Finland
Time consuming IT work
3.2
8.6
48
172
XX9CD
NOMESCO Finland
Very extensive complementary CT
92.7
8.5
9
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.0
8.4
33
90
Z52.89
ICD-10 Finland
Donor of other organ or tissue
+∞
8.4
8
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.5
8.2
38
119
B01AB10
ATC
tinzaparin; parenteral
4.0
8.2
32
87
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
8.9
7.9
16
19
GD1AD
NOMESCO Finland
Thorax CT examination
4.3
7.8
28
70
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
46.3
7.8
9
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
19.0
7.7
11
6
L01EL01
ATC
ibrutinib; oral
25.8
7.6
10
*
1CX01
NOMESCO Finland
NA
+∞
7.3
7
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.7
7.3
51
210
J35.1
ICD-10 Finland
Hypertrophy of tonsils
30.9
7.2
9
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
30.9
7.2
9
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
5.2
7.1
21
43
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
8.6
6.9
14
17
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
17.2
6.8
10
6
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.4
6.8
19
37
ED1AA
NOMESCO Finland
Mandipular X-ray examination
23.1
6.7
9
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
5.3
6.6
19
38
J01MA14
ATC
moxifloxacin; systemic
2.9
6.6
41
158
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
7.7
6.5
14
19
R05
ICD-10 Finland
Cough
2.3
6.5
64
320
A07AA02
ATC
nystatin; oral
3.6
6.5
28
84
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
71.4
6.4
7
*
B72
ICPC
Hodgkin Lymphoma
71.4
6.4
7
*
D10.4
ICD-10 Finland
Benign neoplasm: Tonsil
71.4
6.4
7
*
A05AA02
ATC
ursodeoxycholic acid; oral
14.7
6.4
10
7
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.8
6.4
41
163
9673/3-C77.0
ICD-O-3
Mantle cell lymphoma of lymph nodes of head, face and neck
+∞
6.3
6
*
9673/3-C77.4
ICD-O-3
Mantle cell lymphoma of lymph nodes of inguinal region or leg
+∞
6.3
6
*
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
27.3
6.3
8
*
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
27.3
6.3
8
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
27.3
6.3
8
*
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
12.9
6.1
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3045142) Bone marrow Pathology biopsy report
120
33
61.62
202.77
1.9
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
160
126
27.32
181.54
1.6
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
120
52
38.85
175.80
2.1
1.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
214
332
22.19
157.65
10.2
4.0
u/l
243.6
240.5
0.13
209
311
(40768795) Lymph node Pathology biopsy report
88
24
52.36
146.90
1.3
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
165
196
18.37
143.95
1.7
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
163
192
18.26
142.87
1.7
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
172
246
15.88
130.54
1.8
1.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
76
25
40.94
119.65
3.5
2.3
e9/l
1.2
1.0
0.33
48
12
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
84
45
25.94
110.83
4.1
6.2
iu/ml
537.9
129.0
—
7
7
(4035726)
144
213
12.52
103.72
1.8
1.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
61
16
48.10
101.53
2.8
2.2
%
14.8
17.6
—
19
8
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
58
15
48.17
96.73
2.9
2.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
119
171
11.16
86.06
4.5
2.7
g/l
8.2
10.3
3.37
111
155
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
59
30
24.48
78.56
1.7
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
119
200
9.44
74.73
6.9
4.5
%
0.7
1.0
0.90
90
77
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
75
72
13.73
71.41
2.5
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
74
71
13.68
70.44
2.5
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
66
53
15.86
69.95
2.5
1.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
105
187
8.26
61.55
7.1
4.6
%
0.2
0.2
0.16
77
69
(3004809) Band form neutrophils/100 leukocytes in Blood
57
44
15.90
61.49
4.9
3.8
%
1.1
1.6
0.23
50
38
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
55
41
16.35
60.45
1.5
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
45
23
23.00
59.29
4.3
2.3
e6/l
323.5
640.9
—
21
10
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
52
41
15.26
55.23
1.5
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
95
177
7.52
52.73
6.9
4.5
%
0.5
0.4
0.04
60
55
(3022096) Basophils/100 leukocytes in Blood
235
1036
7.89
50.13
12.6
5.8
%
0.7
0.6
1.35
228
970
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
47
37
14.98
49.81
1.3
1.4
u/ml
97.6
93.1
—
5
8
(3006504) Eosinophils/100 leukocytes in Blood
237
1057
8.01
49.77
12.9
5.8
%
2.7
2.8
0.39
231
987
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
35
15
26.42
49.18
1.2
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
237
1067
7.90
48.92
13.2
6.2
%
10.3
9.0
5.30
231
1002
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
51
49
12.43
47.79
1.8
1.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
237
1083
7.71
47.58
13.2
6.0
%
30.3
25.1
5.86
231
1006
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
48
43
13.20
47.01
1.7
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
128
352
5.75
46.63
4.0
2.3
%
1.7
1.8
0.62
120
316
(42870588) Differential panel, method unspecified - Blood
199
796
5.85
46.20
11.3
5.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
231
1065
6.91
44.81
11.8
5.8
%
52.3
59.2
10.11
226
999
(3023520) Reticulocytes [#/volume] in Blood
107
263
5.88
43.93
4.2
2.4
e9/l
63.7
67.6
0.58
92
209
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
52
58
10.72
43.86
1.9
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
40
30
15.32
43.39
1.7
1.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
76
136
7.23
43.24
2.3
1.8
g/l
0.9
1.6
0.92
69
121
(3019832) Treponema pallidum Ab [Presence] in Serum
56
72
9.41
42.40
1.4
1.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
235
1133
6.84
42.24
12.5
5.6
e9/l
0.6
0.6
0.51
220
966
(3006315) Basophils [#/volume] in Blood
235
1140
6.77
41.72
12.5
5.7
e9/l
0.0
0.0
1.24
220
981
(3019198) Lymphocytes [#/volume] in Blood
236
1153
6.80
41.42
12.8
5.8
e9/l
1.8
1.8
0.13
224
1014
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
45
46
11.41
40.24
1.8
1.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
236
1175
6.59
39.83
13.7
5.8
e9/l
0.2
0.2
2.80
227
1027
(3025159) Blasts/100 leukocytes in Blood
82
175
6.15
38.82
7.7
4.7
%
0.2
0.2
0.04
60
59
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
46
52
10.34
38.26
1.8
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
31
19
18.16
37.18
4.1
3.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
32
21
17.02
37.10
5.9
2.9
%
22.9
38.1
—
10
8
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
38
34
12.72
36.99
3.0
2.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
81
179
5.90
36.81
2.4
1.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
39
37
12.03
36.56
3.0
2.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
41
7
67.92
36.26
2.6
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
243
1302
6.54
35.77
39.7
9.8
e9/l
3.1
4.4
29.55
235
1148
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
136
472
4.56
35.62
3.0
1.9
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
28
16
19.28
34.64
1.1
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
217
1088
5.03
33.98
10.6
5.1
g/l
33.9
34.6
1.02
210
1017
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
28
18
17.12
32.70
2.9
2.6
—
—
—
0
0
(44790047)
34
32
11.91
31.92
1.5
1.6
—
—
—
0
0
(44790048)
34
32
11.91
31.92
1.5
1.6
—
—
—
0
0
(44806118)
34
32
11.91
31.92
1.5
1.6
—
—
—
0
0
(44790049)
34
32
11.91
31.92
1.5
1.6
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
36
6
68.22
31.89
2.7
1.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
23
10
24.91
31.77
4.7
2.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
178
833
3.98
29.12
9.0
4.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
103
331
4.29
29.04
2.4
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
32
32
11.13
28.79
3.4
2.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
32
32
11.13
28.79
3.4
2.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
32
32
11.13
28.79
3.4
2.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
39
51
8.69
28.77
1.4
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
33
35
10.52
28.50
6.2
4.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
120
442
3.94
27.74
13.5
5.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
24
16
16.27
27.39
1.5
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
218
1229
4.18
25.82
12.7
7.4
mmol/l
1.2
1.2
1.58
183
1033
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
98
328
4.01
25.74
2.3
1.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
166
787
3.62
25.65
9.7
3.7
mmol/l
2.3
2.3
0.05
156
675
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
53
112
5.57
24.74
2.5
3.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
43
75
6.56
24.47
1.8
1.7
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
32
40
8.88
24.37
3.3
1.6
pg
33.8
33.1
0.39
32
40
(40765096) Chromosome analysis panel by Banding
30
9
36.98
23.86
1.1
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
21
15
15.02
23.01
2.0
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
31
40
8.56
22.99
1.5
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
202
1134
3.62
22.89
10.9
6.5
mmol/l
1.2
1.2
0.58
196
1012
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
22
11.81
22.73
1.9
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
30
38
8.70
22.57
1.4
1.1
u/ml
473.5
226.0
—
10
22
(3004588) Protein electrophoresis panel - Serum or Plasma
68
191
4.35
22.44
1.7
2.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
21
16
14.08
22.20
2.0
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
153
737
3.30
22.14
9.5
4.7
ph
7.4
7.4
0.58
44
138
(3017354) Segmented neutrophils/100 leukocytes in Blood
26
28
10.11
22.08
4.8
3.7
%
54.7
56.0
0.07
19
22
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
24
24
10.82
21.44
2.0
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
31
45
7.60
20.80
2.5
3.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
28
37
8.27
20.32
1.1
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
19
15
13.49
19.62
4.5
2.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
19
15
13.49
19.62
4.5
2.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
101
403
3.32
19.61
2.0
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
19
16
12.64
18.87
4.5
2.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
19
16
12.64
18.87
4.5
2.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
19
16
12.64
18.87
4.5
2.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
19
16
12.64
18.87
4.5
2.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
19
16
12.64
18.87
4.5
2.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
94
372
3.27
18.34
2.2
1.4
g/l
1.9
2.8
3.86
75
222
(3037692) Legionella sp identified in Specimen by Organism specific culture
18
15
12.73
17.97
1.5
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
122
567
3.00
17.93
25.0
7.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
83
309
3.37
17.85
1.7
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
12
14.06
16.92
1.1
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
172
994
2.81
16.33
22.3
10.6
e9/l
0.0
0.0
0.41
159
811
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
22
9
26.32
16.26
1.4
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
27
44
6.67
16.24
5.7
3.2
%
51.2
61.1
1.90
27
44
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
36
78
5.13
16.13
1.6
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
34
73
5.15
15.38
1.6
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
31
64
5.31
14.63
1.1
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
33
74
4.91
14.18
2.2
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
69
262
3.15
14.07
4.4
4.3
mmol/l
2.2
1.7
0.82
56
198
(3044640) Blood type and Crossmatch panel - Blood
141
779
2.59
14.01
6.8
2.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
233
1649
3.16
13.96
8.0
4.4
mm/h
16.4
13.9
1.32
222
1495
(3028433) Virus identified in Specimen by Culture
15
14
11.25
13.86
1.5
1.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
24
41
6.29
13.76
1.2
1.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
247
1818
3.52
13.61
27.9
8.2
u/l
79.7
82.0
0.45
242
1688
(40768804) Tissue Pathology biopsy report
151
874
2.53
13.43
2.8
2.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
15
15
10.49
13.24
1.0
1.1
—
—
—
0
0
(3012544) pH of Venous blood
69
271
3.03
13.21
4.3
4.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
174
1082
2.54
13.18
9.6
4.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
40
111
4.02
13.12
1.5
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
15
16
9.84
12.65
1.1
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
124
672
2.48
12.50
3.7
3.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
70
286
2.91
12.43
7.8
2.7
umol/l
4.8
10.3
3.96
64
259
(3000850) Epithelial cells [#/volume] in Urine
107
545
2.53
12.28
2.9
2.8
e6/l
3.1
3.9
0.69
95
481
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
20
32
6.64
12.17
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
19
29
6.94
12.07
1.0
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
18
26
7.32
12.00
1.0
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
15
5
31.51
11.76
1.9
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
110
578
2.46
11.71
6.0
2.5
—
—
—
0
0
(3026782) Osmolality of Urine
102
519
2.49
11.63
3.0
3.3
mosm/kgh2o
547.7
573.2
0.55
91
445
(3002582) Erythrocytes [#/volume] in Urine
135
780
2.38
11.59
4.0
3.7
e6/l
24.2
145.6
0.91
112
638
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
13
13
10.43
11.42
3.2
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
13
13
10.43
11.42
3.2
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
23
47
5.23
10.93
1.8
2.8
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
16
23
7.31
10.68
1.8
1.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
125
718
2.31
10.66
3.8
3.5
e6/l
0.2
0.4
1.39
102
568
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
150
931
2.28
10.61
4.0
3.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
12
12
10.39
10.51
3.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
12
12
10.39
10.51
3.3
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
58
234
2.85
10.43
6.6
8.8
—
—
—
0
0
(3000012) Reticulocyte production index
13
15
9.03
10.31
1.4
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
102
553
2.31
9.82
1.7
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
205
1478
2.34
9.75
7.8
5.0
mmol/l
6.5
6.9
2.73
200
1397
(3018095) Leukocytes [#/volume] in Urine
141
877
2.19
9.66
4.7
4.1
e6/l
48.1
146.0
0.70
116
679
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
62
4.32
9.45
1.4
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
25
62
4.32
9.45
1.4
1.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
211
1552
2.34
9.38
5.6
4.5
e6/l
2.4
2583.1
—
7
31
(42529406) Shigella sp [Presence] in Stool by Culture
25
63
4.25
9.26
1.4
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
14
9
16.26
9.12
6.0
4.3
%
50.2
54.6
—
14
9
(3035933) Granulocytes/100 leukocytes in Blood
13
7
19.36
9.01
1.1
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
19
40
5.01
8.72
1.3
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
16
29
5.78
8.59
3.7
2.2
—
—
—
0
0
(3009343) pH of Capillary blood
49
201
2.73
8.46
4.7
3.9
ph
7.5
7.4
1.88
11
20
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
12
7
17.82
8.14
2.2
1.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
48
205
2.61
7.63
4.7
3.8
kpa
4.9
5.1
1.04
48
189
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
42
171
2.70
7.33
1.8
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
26
80
3.47
7.30
1.5
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11
16
7.11
7.20
1.2
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
28
93
3.23
6.98
1.3
3.8
mg/l
56.1
147.3
0.70
23
74
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
28
93
3.23
6.98
1.3
3.8
mg/l
34.5
41.4
0.38
21
75
(3032080) INR in Blood by Coagulation assay
157
1103
1.93
6.93
12.6
10.7
inr
1.3
1.4
0.29
51
303
(1616796) Gas panel - Central venous blood
22
63
3.70
6.86
3.5
3.9
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
20
58
3.63
6.13
2.6
2.5
%
14.4
15.9
1.24
14
32
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
14
31
4.70
6.05
3.6
1.7
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
54
3.70
5.99
1.5
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
54
3.70
5.99
1.5
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
130
892
1.83
5.88
3.3
2.7
ug/l
517.2
185.9
5.24
117
805
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
20
60
3.51
5.84
3.1
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
14
32
4.55
5.83
3.6
1.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
14
32
4.55
5.83
3.6
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
32
4.55
5.83
3.6
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
32
4.55
5.83
3.6
1.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
34
140
2.62
5.79
1.5
1.7
g/l
1.6
1.5
0.14
26
123
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
39
172
2.47
5.77
2.3
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
54
275
2.19
5.75
6.0
3.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
27
99
2.91
5.71
3.4
2.5
u/ml
0.4
0.3
0.42
21
52
(3005988) Vibrio sp identified in Specimen by Organism specific culture
14
33
4.41
5.62
3.6
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
58
307
2.11
5.60
2.3
1.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
21
5.41
5.57
1.3
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
20
62
3.39
5.56
2.9
2.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
66
369
2.02
5.50
10.4
6.9
mmol/l
105.7
103.8
2.93
60
358
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
29
113
2.74
5.49
4.9
2.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
8
5
16.39
5.44
1.3
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
5
16.39
5.44
1.4
3.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
19
58
3.44
5.41
3.2
4.7
mmol/l
1.7
1.9
0.13
11
38
(3026389) Candida sp identified in Specimen by Organism specific culture
11
22
5.16
5.30
1.3
1.2
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
11
22
5.16
5.30
2.1
1.9
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
5
0
+∞
5.22
1.0
0.0
—
—
—
0
0
(3013862) HLA-DP [Type]
5
0
+∞
5.22
1.0
0.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
5
0
+∞
5.22
1.0
0.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
5
0
+∞
5.22
1.0
0.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
5
0
+∞
5.22
1.0
0.0
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
23
82
2.96
5.11
2.0
1.9
g/l
0.0
0.0
0.00
23
73
(3002256) Pathology report gross observation
55
295
2.07
5.11
1.6
1.3
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
9
9
10.27
5.06
9.1
2.4
u/l
241.4
232.9
—
9
9
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
101
669
1.79
4.95
1.9
2.1
mg/l
3.1
3.1
0.03
83
581
(3037467) Urinalysis macro (dipstick) panel - Urine
198
1589
1.79
4.90
5.3
4.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
72
431
1.89
4.88
3.6
3.3
e6/l
0.9
1.3
0.45
44
275
(3022313) Gas panel - Capillary blood
33
146
2.42
4.85
5.4
4.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
143
1059
1.70
4.64
3.0
2.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
73
448
1.84
4.56
3.5
3.1
e6/l
0.9
1.0
0.09
45
288
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
102
2.59
4.35
1.9
1.8
g/l
9.1
10.6
0.96
25
85
(3022145) Colonoscopy Study observation
46
245
2.04
4.34
1.3
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
115
2.49
4.31
1.9
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
39
197
2.13
4.22
4.8
4.0
—
—
—
0
0
(3019225) pH of Specimen
45
241
2.03
4.18
7.7
4.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
25
105
2.51
4.11
1.3
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
23
94
2.57
3.99
2.0
1.8
g/l
36.8
36.4
0.13
23
75
(3028626) Oxygen [Partial pressure] in Capillary blood
20
76
2.75
3.99
2.8
2.3
kpa
7.9
7.9
0.07
20
67
(3026008) Bacteria identified in Urine by Culture
101
704
1.67
3.98
4.1
3.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
123
903
1.63
3.95
3.0
3.4
ng/l
1344.0
1926.2
1.29
113
783
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
180
2110
0.61
3.88
5.4
6.7
mmol/mol
40.8
41.4
0.34
158
1934
(40760888) Immunoglobulin light chains.free panel - Serum
18
66
2.84
3.83
1.3
4.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
75
487
1.73
3.82
2.5
1.8
mg/l
1.9
1.6
0.22
66
377
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
7
8
8.93
3.79
1.3
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
24
103
2.45
3.78
2.2
1.7
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
25
111
2.37
3.67
1.4
2.0
u/l
36.6
37.8
0.09
25
96
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
249
2212
1.93
3.63
53.5
18.0
mg/l
21.7
27.7
3.68
243
1833
(3021601) Nitrite [Presence] in Urine by Test strip
142
1099
1.58
3.55
5.2
5.4
estimate
0.0
0.0
0.00
44
215
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
13
6.29
3.52
3.6
4.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
6
10.18
3.51
1.2
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
17
64
2.76
3.46
1.4
1.5
iu/ml
0.0
0.1
—
7
20
(3035350) Ketones [Presence] in Urine by Test strip
142
1106
1.56
3.41
4.0
4.0
estimate
0.0
0.0
0.00
43
213
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
18
5.12
3.40
1.8
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
18
5.12
3.40
1.8
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
143
1117
1.56
3.38
4.2
4.0
estimate
0.0
0.0
0.00
45
201
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
10
7.14
3.38
2.0
1.9
u/ml
1337.7
1083.2
—
7
10
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
18
71
2.64
3.36
1.6
1.8
mg/l
10.3
13.6
1.06
18
64
(3008536) Aspergillus sp Ab [Presence] in Serum
8
14
5.84
3.36
3.8
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
50
305
1.77
3.13
1.3
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
12
5.95
3.04
1.9
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
51
2.83
3.03
1.1
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
17
69
2.56
3.02
2.5
2.1
g/l
113.0
129.8
3.01
17
48
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
40
3.09
3.01
1.2
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
5
10.14
2.99
2.0
1.0
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
5
5
10.14
2.99
2.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
5
5
10.14
2.99
1.0
1.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
9
22
4.19
2.90
1.0
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
75
521
1.59
2.88
2.9
3.8
ng/l
138.4
317.4
0.97
66
444
(3000570) Elastase.pancreatic [Mass/mass] in Stool
16
65
2.55
2.84
1.0
1.5
ug/g
284.0
247.6
—
7
37
(3003740) Influenza virus B Ag [Presence] in Specimen
7
15
4.75
2.61
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
15
4.75
2.61
1.1
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
38
2.97
2.61
1.7
4.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
234
2097
1.62
2.61
43.0
16.6
ml/min/173m2
74.7
74.1
0.17
220
1756
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
7
7.24
2.56
1.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
7
7.24
2.56
1.2
1.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
88
652
1.50
2.50
1.9
1.6
nmol/l
18.0
19.6
0.55
78
553
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
16
4.46
2.49
6.6
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
45
2.74
2.48
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
51
2.62
2.48
1.0
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
51
2.62
2.48
1.2
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
22
3.71
2.38
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
35
210
1.76
2.33
1.4
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
29
3.17
2.24
1.0
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
10
36
2.84
2.22
1.3
1.7
%
90.7
88.8
—
10
36
(3048879) Bone marrow aspiration report
5
9
5.63
2.22
1.4
2.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
48
2.57
2.21
1.1
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
192
2140
0.69
2.20
3.9
4.9
mmol/l
1.3
1.4
1.23
164
1916
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
107
848
1.42
2.10
2.3
2.2
nmol/l
81.2
76.1
0.96
98
736
(4015189)
5
10
5.07
2.08
1.8
3.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
20
3.56
2.07
1.7
4.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
12
50
2.46
2.05
1.6
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
15
4.06
2.05
1.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
9
33
2.78
1.95
1.2
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
33
2.78
1.95
2.7
4.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
34
2.70
1.88
1.1
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
26
153
1.77
1.87
3.1
3.1
e9/l
6.8
4.1
0.43
20
108
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
17
3.58
1.84
1.3
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
33
209
1.65
1.84
2.3
2.7
u/l
31.4
36.9
0.46
21
175
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
196
2155
0.72
1.83
4.0
4.9
mmol/l
4.6
4.4
1.68
171
1955
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
202
2210
0.71
1.82
4.3
5.5
mmol/l
2.7
2.6
1.74
169
1987
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
54
2.28
1.76
1.0
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
30
2.71
1.73
1.0
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
48
0.00
1.71
0.0
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
79
613
1.40
1.71
4.2
3.7
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
10
43
2.37
1.62
1.3
1.5
mmol/l
3.3
3.8
—
10
38
(3020682) Albumin/Creatinine [Ratio] in Urine
66
840
0.72
1.52
3.7
4.0
mg/mmol
15.0
10.1
0.21
38
560
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
125
1058
1.32
1.52
4.3
4.3
ng/l
27.9
46.0
1.86
109
822
(3027273) Bicarbonate [Moles/volume] in Venous blood
24
148
1.68
1.50
5.0
3.3
mmol/l
25.3
24.4
1.03
24
142
(3044889) 12 lead EKG panel
186
1667
1.33
1.49
5.3
4.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
43
306
1.48
1.48
2.2
4.4
ug/l
2.3
56.9
1.35
33
259
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
28
2.54
1.46
1.0
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
32
215
1.55
1.43
5.4
4.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
78
621
1.35
1.43
4.9
4.2
estimate
0.0
0.0
0.00
40
198
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
105
875
1.31
1.40
4.4
4.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
23
145
1.64
1.33
6.7
3.0
%
1.2
1.2
0.07
23
145
(3012516) Albumin [Mass/volume] in Urine
63
792
0.74
1.32
2.8
3.3
mg/l
77.6
220.2
0.63
38
542
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
192
2083
0.77
1.31
3.9
4.4
mmol/l
1.4
1.3
0.65
166
1863
(4062490)
6
24
2.53
1.31
1.3
1.3
—
—
—
0
0
(3013512) EKG study
94
779
1.31
1.30
4.9
4.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
18
2.81
1.29
1.0
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
30
204
1.53
1.28
2.1
2.3
ug/g
141.3
136.1
0.04
24
164
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
9
44
2.08
1.28
1.2
1.5
e6/l
258.4
190.3
—
9
35
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
9
44
2.08
1.28
1.2
1.4
e6/l
12.2
17.7
—
9
34
(3009542) Hematocrit [Volume Fraction] of Blood
206
1893
1.31
1.26
40.2
19.2
%
36.6
39.2
4.04
126
1193
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
156
1384
1.28
1.26
3.6
3.3
u/l
60.9
58.9
0.09
144
1279
(3045788) Cell count panel - Pleural fluid
8
36
2.26
1.25
2.0
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
45
2.03
1.24
1.1
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
69
551
1.33
1.23
1.7
1.7
nmol/l
1312.6
1200.6
0.39
54
421
(3003396) Base excess in Arterial blood by calculation
48
362
1.39
1.22
7.0
7.0
mmol/l
2.0
1.2
0.58
35
280
(3009508) Creatinine [Moles/volume] in Urine
65
801
0.76
1.18
2.8
3.2
mmol/l
6.7
7.8
2.30
49
663
(3012441) Differential panel - Pleural fluid
8
39
2.08
1.16
1.6
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
43
561
0.73
1.14
2.1
1.7
mmol/l
1.5
1.4
0.69
31
454
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
129
1453
0.80
1.11
4.9
5.2
ug/l
3.9
2.7
0.29
114
1271
(3020891) Body temperature
19
120
1.62
1.11
4.7
4.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
64
513
1.32
1.11
3.6
4.0
—
—
—
0
0
(3000492) Spirometry study
27
186
1.50
1.11
1.3
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
74
1.79
1.08
1.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
22
2.29
1.04
4.4
3.5
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
7
34
2.08
1.03
3.4
2.3
nmol/l
2.3
8.6
—
7
34
(21494755) Public health laboratory ask at order entry panel
5
108
0.45
1.03
1.4
1.5
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
16
99
1.65
1.02
2.6
3.6
mmol/l
3.6
3.9
1.20
11
90
(3020564) Creatinine [Moles/volume] in Serum or Plasma
247
2351
1.36
1.01
54.3
21.2
umol/l
88.8
87.8
0.15
247
2351
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
116
0.51
0.96
1.8
1.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
13
206
0.61
0.93
1.2
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
240
2283
1.31
0.92
36.8
17.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
8
43
1.88
0.88
5.5
3.4
mmol/l
105.1
105.7
—
8
43
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
43
1.88
0.88
5.5
3.4
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
8
43
1.88
0.88
5.5
3.4
mmol/l
4.2
4.1
—
8
43
(3051611) Lipemic interference index of Serum or Plasma
6
30
2.02
0.87
4.5
3.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
28
205
1.41
0.87
3.3
3.4
ml/min/173m2
52.5
57.2
—
6
84
(21494890) Protein electrophoresis panel - 24 hour Urine
6
31
1.95
0.85
1.0
3.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
18
122
1.51
0.82
1.1
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
32
1.89
0.82
5.8
3.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
118
1053
1.20
0.80
2.1
2.1
pmol/l
91.5
90.8
0.07
73
577
(4268621)
0
24
0.00
0.79
0.0
2.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
25
0.00
0.79
0.0
1.2
—
1.7
—
0
6
(4146454)
0
26
0.00
0.79
0.0
2.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
47
381
1.28
0.77
1.1
1.2
u/ml
0.8
1.2
1.03
12
99
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
0
28
0.00
0.76
0.0
1.2
—
11.1
—
0
14
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
5
24
2.10
0.75
1.6
1.2
u/l
94.6
48.4
—
5
17
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
14
92
1.55
0.73
1.5
3.3
pmol/l
3.9
4.4
1.89
14
79
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
25
2.02
0.73
1.0
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
12
76
1.60
0.73
4.3
3.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
12
77
1.58
0.69
3.8
6.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
104
1154
0.85
0.67
4.8
4.6
%
21.0
21.5
0.14
57
584
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
28
1.80
0.66
1.8
1.8
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
11
70
1.59
0.66
1.1
1.1
u/ml
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
250
2417
1.26
0.63
67.9
25.9
e9/l
6.5
7.0
0.83
244
2340
(3026361) Erythrocytes [#/volume] in Blood
250
2417
1.26
0.63
67.9
25.8
e12/l
4.0
4.5
28.46
244
2338
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
164
1531
1.17
0.61
3.5
3.5
pmol/l
14.9
15.0
0.20
146
1343
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
8
51
1.58
0.61
1.0
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
85
754
1.18
0.60
6.1
3.6
u/l
47.9
34.6
0.65
80
715
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
6
36
1.68
0.57
2.8
2.8
u/ml
6394.4
3.0
—
6
36
(3024928) Oxygen saturation in Venous blood
9
60
1.52
0.55
1.1
3.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
65
1.40
0.51
1.6
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
75
831
0.87
0.46
3.5
3.0
ug/l
0.7
0.8
0.21
55
563
(3019150) Specific gravity of Urine by Refractometry
44
505
0.85
0.42
4.7
4.3
kg/l
1.0
1.0
—
6
79
(3011288) Drugs identified in Urine by Screen method
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.3
—
87.3
—
0
9
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
17
0.00
0.41
0.0
1.2
—
11.7
—
0
6
(4281824)
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
9
68
1.33
0.38
1.3
1.2
—
3.0
—
0
6
(1761868) Lipid panel - Serum or Plasma
61
676
0.88
0.38
3.0
3.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
43
1.40
0.35
1.5
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
164
1.24
0.33
12.6
8.7
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
6
47
1.28
0.32
1.2
2.7
%
62.2
65.7
—
6
47
(3049717) Cytology report of Urine Cyto stain
17
140
1.23
0.28
1.7
3.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
211
2164
0.91
0.28
5.0
5.1
mmol/l
6.0
6.2
1.28
187
1935
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
67
1.20
0.26
1.5
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
26
298
0.86
0.26
1.2
1.2
u/ml
1.2
14.9
1.92
11
110
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
35
315
1.13
0.22
11.2
9.2
—
—
—
0
0
(4010399)
15
178
0.83
0.22
1.5
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
29
325
0.88
0.22
1.1
1.2
iu/ml
11.7
34.2
—
5
99
(3022217) INR in Platelet poor plasma by Coagulation assay
37
408
0.89
0.22
25.4
27.3
inr
1.5
1.4
—
7
44
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
12
98
1.23
0.21
1.4
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
13
0.00
0.21
0.0
4.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
61
570
1.09
0.20
1.5
1.8
pmol/l
476.0
426.3
0.52
50
476
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
50
1.20
0.20
2.2
1.7
—
—
—
0
0
(4094501)
6
53
1.13
0.19
1.3
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
25
225
1.12
0.16
3.6
3.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
70
1.15
0.16
1.3
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
9
106
0.84
0.13
1.7
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
12
104
1.16
0.12
1.2
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
15
167
0.89
0.11
3.7
2.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
198
1953
1.04
0.10
4.2
4.3
mu/l
2.3
2.0
1.54
178
1720
(3023183) Ammonium ion [Moles/volume] in Plasma
6
75
0.80
0.07
1.5
2.5
umol/l
26.7
34.6
—
6
60
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
74
1.08
0.07
1.5
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
134
1.05
0.00
3.0
2.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
12
122
0.98
0.00
1.2
1.2
—
50.1
—
0
9
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
51
0.98
0.00
1.4
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
215.6
—
0
8
(3044007) Cell count panel - Peritoneal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
25.6
—
0
7
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
11.1
—
0
5
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
89
0.90
0.00
1.1
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
5.1
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
0.3
—
0
6
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
7
0.00
0.00
0.0
6.1
—
7.0
—
0
7
(3022689) Creatine [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
7.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
14
140
1.00
0.00
4.6
4.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
27.6
—
0
9
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
95
0.95
0.00
3.7
1.9
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
8.8
—
0
5
(3011544) Albumin [Mass/volume] in Pleural fluid
0
9
0.00
0.00
0.0
1.0
—
18.3
—
0
9
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
18.7
—
0
6
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.4
—
86.4
—
0
5
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
7.8
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4034850)
8
86
0.93
0.00
26.6
13.2
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
27.2
—
0
6
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
17.3
—
1420.0
—
0
7
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
7
0.00
0.00
0.0
3.0
—
13.2
—
0
7
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
7.7
—
—
—
0
0
(4133840)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
11.6
—
927.1
—
0
7
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_MANTLE_CELL_LYMPHOMA – Mantle cell lymphoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).